U jakich pacjentów nowe leki powinny być badane na początku?

Muthiah Vaduganathan; Vinay Prasad. Modern Drug Development: Which Patients Should Come First? , LINK: JAMA online (dostępny pełen tekst)

The goal of drug development is to expeditiously bring safe, effective medications to the patients who need them most. In parallel with the traditional phases of drug testing (1, 2, and 3), drug manufacturers must choose the patient populations and the indications for which drugs will first be studied. Historically, novel agents ordinarily have been introduced in patients with advanced disease states …

Opracowane na podstawie: JAMA / 24 listopada 2014

Dodaj komentarz